Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 3, Issue 1, 2009, Pages 73-80

  Khansari, Nemat ^a   Shakiba, Yadollah ^a   Mahmoudi, Mahdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age related diseases; Angiogenesis; Antioxidant; Cancer; Chronic inflammation; DNA damage; Free radicals

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 2; CYSTEINE; FREE RADICAL; GAMMA INTERFERON; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MITOCHONDRIAL DNA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT;

AGING; ANGIOGENESIS; CANCER RISK; CARCINOGENESIS; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; HUMAN; IMMUNE SYSTEM; LIPID OXIDATION; MALIGNANT TRANSFORMATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHRONIC DISEASE; GENETIC PREDISPOSITION; INFLAMMATION; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY;

AGING; ANIMALS; ANTIOXIDANTS; CHRONIC DISEASE; DNA DAMAGE; FREE RADICALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; NEOPLASMS; OXIDATIVE STRESS;

EID: 61449125226     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221309787158371     Document Type: Review

References (93)

1. Allavena P, Sica A, Solinas G, Porta C, Mantovanii A. The inflammatory micro environment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008; 66(1): 1-9.
2. Hold GL, El-Omar ME. Genetic aspects of inflammation and cancer. Biochem J 2008 1; 410(2): 225-235.
3. Harman D. Free radical theory of aging: history. In: Emerita I, Chance B Eds., Free Radicals and Aging, Birkhauser-Verlag, Basel 1992; 1-10.
4. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39(1): 44-84.
5. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1): 1-40.
6. Wickens AP. Ageing and the free radical theory. Respir Physiol 2001; 128(3): 379-391.
7. Inoue M, Sato EF, Nishikawa M, et al. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003; 10(23): 2495-2505.
8. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition 1996; 12(4): 274-277.
9. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44: 239-267
10. Roberts RA, Gary PE, Ju C, et al. Role of the Kuppfer cell in mediating hepatic toxicity and arcinogenesis. Toxicol Sci 2007; 96: 2-15.
11. Mateos R, Bravo L. Chromatographic and electrophoretic methods for analysis of biomarkers of oxidative damage to macromolecules (DNA, lipids, and proteins). J Sep Sci 2007; 30: 175-179.
12. Lippman RD. Lipid peroxidation and metabolism in aging. In: Rothstein, M. Ed Review of Biological Research in Aging, Alan R. Liss, New York 1983; 1: 315-342.
13. Ran O, Gu M, Van Remmen H, et al. Glutatione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity. J Neurosci Res 2006; 84: 202-208.
14. Stadtman ER. The status of oxidatively modified proteins as a marker of aging. In: Esser K, Martin GM. Eds. Molecular Aspects of Aging. Wiley, Chichester 1995; 129-144.
15. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90(17): 7915-7922.
16. Linn S. DNA repair in mitochondria: How is it limited? What is its function? In: Esser K, Martin GM. Eds. Molecular Aspects of Aging. Wiley, Chichester 1995; 199-225.
17. Johnson FB, Sinclair D.A, Guarente L. Molecular biology of aging. Cell1999; 96: 291-302.
18. Pastoret A, Federici G, Bertini E, Piemonti F. Analysis of glutathione: Implication in redox and detoxification. Clin Chim Acta 2003; 333: 19-39.
19. Ryan KA, Smith MF Jr, Sanders MK, Ernst PB. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF kappaB and interleukin-8 expression. Infect Immun 2004; 72: 2123-2130.
20. Emmendoerffer A, Hecht M, Boeker T, Mueller M, Heinrich U. Role of inflammation in chemical-induced lung cancer. Toxicol Lett 2000; 112-113: 185-191.
21. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKC epsilon, ROS and MPT. Am J Physiol Heart Circ Physiol 2007; 294: 874-882.
22. Flalkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007; 42: 153-164.
23. Segal W. How superoxide production by neutrophil leukocytes kill microbe. Novartis Found Symp 2006; 279: 92-98.
24. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
25. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage and repair. Langenbecks Arch Surg 2006; 391: 499-510.
26. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008; 11(1): 1-15.
27. Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol 2004; 14: 259-266.
28. Haddad JJ. Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun 2002 Oct 4; 297(4): 700-713.
29. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10: 295-331.
30. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
31. Chapple IL. C Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 1997; 24: 287-296.
32. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007; 121(11): 2381-2386.
33. Dedera DA, Urashima M, Chauhan D, et al. Interleukin-6 is required for pristaine-induced plasma cell hyperplasia in mice. Br J Haematol 1996; 94: 53-61.
34. Hinson RM, Williams JA, Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 1996; 93: 4885-4890.
35. Shacter E, Arzadon GK, Williams J. Elevation of IL-6 in response to a chronic inflammatory stimulus in mice: Inhibition by indomethacin. Blood 1992; 80: 194-202.
36. Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-a are resistant to skin carcinogenesis. Nat Med 1999; 5: 828-831.
37. Zouki C, Jozsef L, Ouellet S, Paquette Y, Filep JG. Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol 2001; 69: 815-824.
38. Mantovanii A, Pierotti MA. Cancer and inflammation: A complex relationship. Cancer Lett 2008 (article in press).
39. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852.
40. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995; 92: 5258-5265.
41. Slaga TJ, Lichti U, Hennings H, Elgjo K, Yuspa SH. Effects of tumor promoters and steroidal anti-inflammatory agents on skin of newborn mice in vivo and in vitro. J Natl Cancer Inst 1978; 60: 425-431.
42. Hinson RM, Williams JA, Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: Possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 1996; 93: 4885-4890.
43. kappaB in cytokine gene regulation. Adv Immunol1997; 65: 1-46.
44. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11: 457-465.
45. Shacter E, Arzadon GK, Williams J. Elevation of IL-6 in response to a chronic inflammatory stimulus in mice: Inhibition by indomethacin. Blood 1992; 80: 194-202.
46. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 2000; 51: 511-523.
47. Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 2000; 1470: M69-M78.
48. Howe LR, Dannenberg AJ. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. Semin Oncol 2002; 29: 111-119.
49. Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclooxygenase 2: A pharmacological target for the prevention of cancer. Lancet Oncol 2001; 2: 544-551.
50. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase- 2: A target for the prevention and treatment of breast cancer. Endocr Relat Cancer 2001; 8: 97-114.
51. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002; 108: 153-164.
52. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 1999; 57: 231-245.
53. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161-1208.
54. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-370.
55. Radi R. Peroxynitrite reactions and diffusion in biology. Chem Res Toxicol 1998; 11; 720-721.
56. Thomas DD, Liu X, Kantrow SP, Lancaster JR. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci USA 2001; 98: 355-360.
57. Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 1995; 371: 86-88.
58. Yermilov V, Rubio J, Becchi M, Friesen MD, Pignatelli B, Ohshima H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 1995; 16: 2045-2050.
59. Akaike T, Okamoto S, Sawa T, et al. 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci USA 2003; 100: 685-690.
60. Zaki MH, Akuta T, Akaike T. Nitric oxide-induced nitrative stress involved in microbial pathogenesis. J Pharmacol Sci 2005; 98: 117-129.
61. Suzuki N, Yasui M, Geacintov NE, Shafirovich V, Shibutani S. Miscoding events during DNA synthesis past the nitration-damaged base 8-nitroguanine. Biochemistry 2005; 44: 9238-9245.
62. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428.
63. Albring M, Griffith J, Attardi G. Association of a protein structure of probable membrane derivation with HeLa cell mitochondrial DNA near its origin of replication. Proc Natl Acad Sci USA 1977; 74: 1348-1352.
64. Clayton DA. Transcription of the mammalian mitochondrial genome. Annu Rev Biochem 1984; 53: 573-594.
65. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997; 94: 514-519.
66. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997; 272: 19633-19636.
67. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272: 20313-20316.
68. Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000; 287: 2017-2019.
69. Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 2000; 60: 4231-4237.
70. Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998; 20: 291-293.
71. Carcamo JM, Golde DW. Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-Myc. Mutat Res 2006; 593: 64-79.
72. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res 1996; 6: 639-645.
73. Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227: 375-381.
74. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3[4): 276-285.
75. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J 2000; 14: 1889-1900.
76. Pervin S, Singh R, Chaudhuri G. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line [MDA-MB-231): potential role of cyclin D1. Proc Natl Acad Sci USA 2001; 98: 3583-3588.
77. Martinez DE. Rejuvenation of the disposable soma: repeated injury extends lifespan in asexual annelid. Exp Gerontol 1996; 31: 699-704.
78. Martin GM. Modalities of gene action predicted by the classical evolutionary biological theory of aging. Ann NY Acad Sci 2007; 1000: 14-20.
79. Gilca M, Stoian I, Atarasiu V, et al. The oxidative hypothesis of senescence. J Postgrad Med 2007; 53: 207-213.
80. Figueiredo PA, Mota MP, Appell HJ, Duarte JA. The role of mitochondria in aging of skeletal muscle. Biogerontology 2008; 9: 67-84.
81. Koya, K.: US20080119440 (2008).
82. Dalle-Donne I, Scaloni A, Giustarini D, Milzani A. Biomarkers of oxidative damage in human diseases. Clin Chem 2006; 52: 601-603.
83. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56.
84. Barnett YA, King CM. Investigation of antioxidant status. DNArepair capacity and mutation as a function of age in humans. Mut Res 1995; 338: 115-128.
85. Stadtman ER. Role of oxidant species in aging. Curr Med Chem 2004; 11: 1105-1112.
86. Rikans LE, Hornbrook KR. Lipid peroxidation, antioxidant protection and aging. Biochim Biophys Acta 1997; 1362: 116-127.
87. Rikans LE, Moore DR, Snowden CD. Sex-dependent differences in the effects of aging on antioxidant defense mechanisms of rat liver. Biochim Biophys Acta 1991; 1074: 195-200.
88. Perez R, Lopez M, Barja de Quiroga G. Aging and lung antioxidant enzymes, glutathione, and lipid peroxidation in the rat. Free Radic Biol Med 1991; 10: 35-39.
89. Myhill, P.R., Driscoll, W.J.: US20087384655 (2008).
90. Massie HR, Aiello VR, Banziger V. Iron accumulation and lipid peroxidation in aging C57BL/6J mice. Exp Gerontol 1983; 18: 277-285
91. Koizumi A, Weindruch R, Walford RL. Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice. J Nutr 1987; 117: 361-367.
92. Heaney, A. P., Hui, H.: WO07025238 (2007).
93. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the generative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922.